WS #13488

19:22→19:51 UTC

From 499 msgs · 7 key-dev

Eli Lilly reports Q2 revenue +48% and EPS $8.38 vs $6.01 est., raises FY guidance and price target to $1,300, reinforcing GLP-1 leadership.

Eli Lilly Beat-and-Raise

Eli Lilly reports Q2 revenue +48% and EPS $8.38 vs $6.01 est., raises FY guidance and price target to $1,300, reinforcing GLP-1 leadership.